The US Food and Drug Administration is seeking feedback on two draft guidance documents relating to the pre-market review of medical devices. The first guidance explains the factors the FDA considers when making benefit-risk determinations in pre-market reviews, and the second guidance sets out design considerations for pivotal clinical investigations1,2...
Please login to read the full article.
